The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer
- 1 November 2009
- journal article
- research article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 11 (11) , 753-759
Abstract
Peritoneal carcinomatosis in women frequently has an ovarian origin. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) along with radical surgery/peritonectomy could present a new therapeutic approach with curative intention. The purpose of this research is to evaluate the role of the administration of HIPEC.Keywords
This publication has 32 references indexed in Scilit:
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancerAnnals of Oncology, 2007
- Radical surgery‐peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancerJournal of Surgical Oncology, 2006
- Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of MilanEuropean Journal of Surgical Oncology, 2006
- Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal disseminationEuropean Journal of Surgical Oncology, 2006
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- Ovarian cancer treatment: what is newInternational Journal of Gynecological Cancer, 2003
- Extensive cytoreductive surgery combined with intra-operative intraperitoneal perfusion with cisplatin under hyperthermic conditions (OVHIPEC) in patients with recurrent ovarian cancer: a feasibility pilotEuropean Journal of Surgical Oncology, 2000
- Carcinoses péritonéales traitées par chirurgie de réduction tumorale et chimiohyperthermie intrapéritonéaleAnnales de Chirurgie, 2000
- The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group studyGynecologic Oncology, 1992